Cited by 90Vitamin D Research StudiesSteroid Chemistry and BiochemistryPharmacogenetics and Drug Metabolism

Production of 22-hydroxy metabolites of vitamin D3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells

Open access
Tuckey, Robert C., Li, Wei, Shehabi, Haleem Z., Janjetovic, Zorica, Nguyen, Minh N., Kim, Tae-Kang, Chen, Jianjun, Howell, Danielle E. +4 more·2011·Drug Metabolism and Disposition

Abstract

Cytochrome P450scc (CYP11A1) can hydroxylate vitamin D(3), producing 20S-hydroxyvitamin D(3) [20(OH)D(3)] and 20S,23-dihydroxyvitamin D(3) [20,23(OH)(2)D(3)] as the major metabolites. These are biologically active, acting as partial vitamin D receptor (VDR) agonists. Minor products include 17-hydroxyvitamin D(3), 17,20-dihydroxyvitamin D(3), and 17,20,23-trihydroxyvitamin D(3). In the current study, we have further analyzed the reaction products from cytochrome P450scc (P450scc) action on vitamin D(3) and have identified two 22-hydroxy derivatives as products, 22-hydroxyvitamin D(3) [22(OH)D(3)] and 20S,22-dihydroxyvitamin D(3) [20,22(OH)(2)D(3)]. The structures of both of these derivatives were determined by NMR. P450scc could convert purified 22(OH)D(3) to 20,22(OH)(2)D(3). The 20,22(OH)(2)D(3) could also be produced from 20(OH)D(3) and was metabolized to a trihydroxyvitamin D(3) product. We compared the biological activities of these new derivatives with those of 20(OH)D(3), 20,23(OH)(2)D(3), and 1α,25-dihydroxyvitamin D(3) [1,25(OH)(2)D(3)]. 1,25(OH)(2)D(3), 20(OH)D(3), 22(OH)D(3), 20,23(OH)(2)D(3), and 20,22(OH)(2)D(3) significantly inhibited keratinocyte proliferation in a dose-dependent manner. The strongest inducers of involucrin expression (a marker of keratinocyte differentiation) were 20,23(OH)(2)D(3), 20,22(OH)(2)D(3), 20(OH)D(3), and 1,25(OH)(2)D(3), with 22(OH)D(3) having a heterogeneous effect. Little or no stimulation of CYP24 mRNA expression was observed for all the analogs tested except for 1,25(OH)(2)D(3). All the compounds stimulated VDR translocation from the cytoplasm to the nucleus with 22(OH)D(3) and 20,22(OH)(2)D(3) having less effect than 1,25(OH)(2)D(3) and 20(OH)D(3). Thus, we have identified 22(OH)D(3) and 20,22(OH)(2)D(3) as products of CYP11A1 action on vitamin D(3) and shown that, like 20(OH)D(3) and 20,23(OH)(2)D(3), they are active on keratinocytes via the VDR, however, showing a degree of phenotypic heterogeneity in comparison with other P450scc-derived hydroxy metabolites of vitamin D(3).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1124/dmd.111.040071

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tuckey, R. C., Li, W., Shehabi, H. Z., Janjetovic, Z., Nguyen, M. N., Kim, T.-K., Chen, J., Howell, D. E., Benson, H. A. E., Sweatman, T., Baldisseri, D. M., & Slominski, A.
Affiliations
  • The University of Western Australia (AU)
  • University of Tennessee Health Science Center (US)
Venue
Drug Metabolism and Disposition
Publisher
Elsevier BV
Published
2011-09
Volume
39
Issue
9
Pages
1577-1588
ISSN
0090-9556 (ISSN-L)
OpenAlex
W2127898028
Cited by
88
References
35
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 7 · 2022: 5 · 2021: 11 · 2020: 5 · 2019: 1 · 2018: 7 · 2017: 6 · 2016: 10 · 2015: 9 · 2014: 9 · 2013: 4 · 2012: 8
FWCI
5.18
Type
journal article
Language
en
Open access
Locations
  • Drug Metabolism and Disposition (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (University of Western Australia) (submittedVersion)
  • eSpace (Curtin University) (submittedVersion)
Funders
  • National Institutes of Health
  • Health Science Center, University of Tennessee
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR052190)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Vitamin D Research Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Steroid Chemistry and Biochemistry
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
vitamin D3 metabolites, cytochrome P450scc, CYP11A1, vitamin D hydroxylation, keratinocyte proliferation, 1,25-dihydroxyvitamin D3
MeSH terms
Calcifediol, Cells, Cultured, Cholecalciferol, Cholesterol Side-Chain Cleavage Enzyme, Dihydroxycholecalciferols, Humans, Hydroxycholecalciferols, Magnetic Resonance Spectroscopy, Protein Precursors, Skin, Steroid Hydroxylases, 25-Hydroxyvitamin D3 1-alpha-Hydroxylase, Keratinocytes, Receptors, Calcitriol, Protein Transport, Cell Proliferation, Vitamin D3 24-Hydroxylase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review